Home / Market Reports / Pharma & Healthcare / Global Fukangning Tablets Market Growth 2024-2030

Global Fukangning Tablets Market Growth 2024-2030

Global Fukangning Tablets Market Growth 2024-2030

Product Code:1241785

Published Date: Nov 29,2024

Pages: 157

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global Fukangning Tablets market size is predicted to grow from US$ 48.2 million in 2024 to US$ 66.7 million in 2030; it is expected to grow at a CAGR of 5.6% from 2024 to 2030.

Fukangning Tablets is a Chinese patent medicine, composed of Chinese Angelica, Leonurus japonicus, Rehmannia glutinosa, Cyperus rotundus, White Peony Root, Corydalis yanhusuo, Artemisia argyi, etc. It has the effects of regulating menstruation, nourishing blood, regulating qi and relieving pain, and can be used to treat irregular menstruation, dysmenorrhea and postpartum abdominal pain caused by stagnation of qi and blood.

United States market for Fukangning Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Fukangning Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Fukangning Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Fukangning Tablets players cover Yantai Bohai Pharmaceutical Group Co., Ltd., Guangzhou Xiangxue Pharmaceutical Co., Ltd., Lanzhou Foci Pharmaceutical Co., Ltd., Guangxi Shuangyi Pharmaceutical Co., Ltd., Guangxi Bangqi Pharmaceutical Group Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Fukangning Tablets Industry Forecast” looks at past sales and reviews total world Fukangning Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Fukangning Tablets sales for 2024 through 2030. With Fukangning Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fukangning Tablets industry.

This Insight Report provides a comprehensive analysis of the global Fukangning Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fukangning Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fukangning Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fukangning Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fukangning Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Fukangning Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Film-coated Tablets
    Sugar-coated Tablets

Segmentation by Application:
    Hospital
    Clinic
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Yantai Bohai Pharmaceutical Group Co., Ltd.
    Guangzhou Xiangxue Pharmaceutical Co., Ltd.
    Lanzhou Foci Pharmaceutical Co., Ltd.
    Guangxi Shuangyi Pharmaceutical Co., Ltd.
    Guangxi Bangqi Pharmaceutical Group Co., Ltd.
    Guangxi Fanglue Pharmaceutical Group Co., Ltd.
    Tonghua Baixin Pharmaceutical Co., Ltd.
    Yili Pharmaceutical (Nanning) Co., Ltd.
    Jilin Jurentang Pharmaceutical Co., Ltd.
    Jinhua Kangshou Pharmaceutical Co., Ltd.
    Jiangsu Yihai Pharmaceutical Co., Ltd.
    Shaanxi Kanghui Pharmaceutical Co., Ltd.
    Shaanxi Panlong Pharmaceutical Group Co., Ltd.
    Huaihua Zhenghao Pharmaceutical Co., Ltd.
    Liaoning Dongfangren Pharmaceutical Co., Ltd.
    Henan Zhongjing Pharmaceutical Co., Ltd.
    Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
    Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd.
    Lanzhou Weici Pharmaceutical Co., Ltd.
    Guangxi Weiwe Pharmaceutical Co., Ltd.
    Guangxi Jinsuozi Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report
What is the 10-year outlook for the global Fukangning Tablets market?
What factors are driving Fukangning Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fukangning Tablets market opportunities vary by end market size?
How does Fukangning Tablets break out by Type, by Application?